London‑based private‑equity firm LeapFrog Investments announced plans to allocate up to $100 million to India’s rapidly expanding healthcare market over the next two years. The firm’s global head of healthcare, Biju Mohandas, told Reuters the capital will focus on asset‑light, single‑specialty providers and hospitals that serve patients beyond the country’s major metropolitan areas.
Why India’s Health Market Attracts Capital
India’s healthcare sector, valued at roughly $180 billion in 2023, is projected to grow to $320 billion by 2028, according to government data. Expanding insurance coverage, rising disposable incomes, and a growing emphasis on diagnostics and preventive care are driving demand for quality medical services, especially for chronic disease management.
Target Areas for Investment
LeapFrog is evaluating investments in several high‑need areas, including:
- Hospitals that cater to patients outside major cities, helping bridge the urban‑rural health gap.
- Specialty‑care providers focused on maternal and child health, ophthalmology, and oncology.
Mohandas said the firm’s investment thesis rests on two realities: increasing insurance penetration and a growing middle class with the means to afford quality care.
Existing Footprint and Future Plans
LeapFrog already backs Indian companies such as diagnostics provider Redcliffe Labs and digital‑health platform Healthify. The firm is also exploring opportunities in the pharmaceutical and medical‑equipment sectors.
The new capital will be drawn from an $808 million fund and related co‑investment vehicles, giving LeapFrog more than $1 billion to deploy across Asia and Africa. Recent deployments include investments in the Philippines and Vietnam, and the firm expects substantial opportunities in India over the coming years.
India’s healthcare market has seen robust deal activity, with 594 mergers, acquisitions and private‑equity transactions totaling over $30 billion between 2022 and 2024, according to Grant Thornton Bharat and the Association of Healthcare Providers India. Notable recent deals include KKR’s €1.2 billion acquisition of Medicover Hospital’s India business.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
